Presentation is loading. Please wait.

Presentation is loading. Please wait.

Drug Discovery @ UCIBIO Maria João Ramos Email: mjramos@fc.up.pt www.fc.up.pt/pessoas/mjramos/

Similar presentations


Presentation on theme: "Drug Discovery @ UCIBIO Maria João Ramos Email: mjramos@fc.up.pt www.fc.up.pt/pessoas/mjramos/"— Presentation transcript:

1 Drug Discovery @ UCIBIO
Maria João Ramos

2 Drug Discovery @ UCIBIO
UCIBIO is part of the Laboratório Associado

3 Drug Discovery @ UCIBIO
UCIBIO is part of the Laboratório Associado With members from both Universities:

4 Drug Discovery @ UCIBIO
UCIBIO lies at the interface between CHEM & BIO The DD Line combines the expertise at this interface Its goal is to identify and synthesize new drug candidates with the following characteristics: mM-nM affinity to the target. No toxicity in cell lines and animal models. Good oral bioavailability in animal models. Original and patentable. The wide range of expertise within UCIBIO embraces almost all stages of DD, putting the research line in an ideal situation to accomplish these goals, for the sake of the development of science and welfare of society.

5 Drug Discovery @ UCIBIO
Target Discovery Lead Discovery Lead Optimization ADMET Development Registration Expression Analysis In Vitro Function In vivo validation; (e.g. knockouts) Bioinformatics Traditional Chem. Combinatorial Chem. SBDD High Throuput Screening Medicinal Chemistry Rational Drug Design Oral Activity Absortion Permeation Solubility Distribution Metabolsim Excretion Toxicity Clinical trials; Phases I-III Europe (EMEA or country-by country) U.S.A – FDA Japan (MHLW) Rest of the world 2-3 years year years years years years 10-12 years average cost: 2.6 billion USD (2014)

6 Drug Discovery @ UCIBIO
Preclinical Trials Technology Transfer IN SILICO OPTIMIZATION SYNTHESIS IN VITRO TESTING IN VIVO TESTING TARGET ID & STRUCTURE VIRTUAL SCREENING ADME & SAFETY

7 Drug Discovery @ UCIBIO
Preclinical Trials Technology Transfer IN SILICO OPTIMIZATION SYNTHESIS IN VITRO TESTING IN VIVO TESTING TARGET ID & STRUCTURE VIRTUAL SCREENING ADME & SAFETY

8 Drug Discovery @ UCIBIO
Preclinical Trials Technology Transfer IN SILICO OPTIMIZATION SYNTHESIS IN VITRO TESTING IN VIVO TESTING TARGET ID & STRUCTURE VIRTUAL SCREENING ADME & SAFETY

9 Drug Discovery @ UCIBIO
Preclinical Trials Technology Transfer IN SILICO OPTIMIZATION SYNTHESIS IN VITRO TESTING IN VIVO TESTING TARGET ID & STRUCTURE VIRTUAL SCREENING ADME & SAFETY

10 Drug Discovery @ UCIBIO
Preclinical Trials Technology Transfer IN SILICO OPTIMIZATION SYNTHESIS IN VITRO TESTING IN VIVO TESTING TARGET ID & STRUCTURE VIRTUAL SCREENING ADME & SAFETY

11 Drug Discovery @ UCIBIO
Preclinical Trials Technology Transfer IN SILICO OPTIMIZATION SYNTHESIS IN VITRO TESTING IN VIVO TESTING TARGET ID & STRUCTURE VIRTUAL SCREENING ADME & SAFETY

12 Drug Discovery @ UCIBIO
Preclinical Trials Technology Transfer IN SILICO OPTIMIZATION SYNTHESIS IN VITRO TESTING IN VIVO TESTING TARGET ID & STRUCTURE VIRTUAL SCREENING ADME & SAFETY

13 Drug Discovery @ UCIBIO
Preclinical Trials Technology Transfer IN SILICO OPTIMIZATION SYNTHESIS IN VITRO TESTING IN VIVO TESTING TARGET ID & STRUCTURE VIRTUAL SCREENING ADME & SAFETY

14 Drug Discovery @ UCIBIO
TARGET ID & STRUCTURE VIRTUAL SCREENING IN VITRO TESTING ADME & SAFETY Preclinical Trials Technology Transfer IN SILICO OPTIMIZATION SYNTHESIS IN VITRO TESTING IN VIVO TESTING

15 Drug Discovery @ UCIBIO
1-DRUGS TARGETS & BIOMARKERS Ribeiro et al, Biofactors, 42, , 2016. 2-THEORETICAL & COMPUTATIONAL BIOCHEMISTRY Neves et al, PNAS, 114, E4724-E4733, 2017. 3-BIOMODELS, BIOANALYTICS AND BIOPHYSICS Costa et al, Advanced Drug Delivery Reviews, 102, , 2016. DTB – DRUGS TARGETS & BIOMARKERS SMB – STRUCTURAL & MOLECULAR BIOLOGY TBC – THEORETICAL & COMPUTATIONAL BIOCHEMISTRY FMN – FUNCTIONAL MOLECULES & NANOMATERIALS TOXI – TOXICOLOGY BBB - BIOMODELS, BIOANALYTICS AND BIOPHYSICS 4-FUNCTIONAL MOLECULES & NANOMATERIALS Barbosa et al, Carbohydrate Polymers, 165, , 2017. 5-TOXICOLOGY Valente et al, Toxicol Sci., 153, , 2016.

16 Drug Discovery @ UCIBIO
TARGET ID & STRUCTURE VIRTUAL SCREENING IN VITRO TESTING ADME & SAFETY DRUGS TARGETS & BIOMARKERS THEORETICAL & COMPUTATIONAL BIOCHEMISTRY FUNCTIONAL MOLECULES & NANOMATERIALS BIOMODELS, BIOANALYTICS AND BIOPHYSICS FUNCTIONAL MOLECULES & NANOMATERIALS TOXICOLOGY IN SILICO OPTIMIZATION SYNTHESIS IN VITRO TESTING IN VIVO TESTING DTB – DRUGS TARGETS & BIOMARKERS – Natércia Teixeira TBC – THEORETICAL & COMPUTATIONAL BIOCHEMISTRY – Maria João Ramos FMN – FUNCTIONAL MOLECULES & NANOMATERIALS - Maria da Conceição Rangel TOXI – TOXICOLOGY - Félix Carvalho BBB - BIOMODELS, BIOANALYTICS AND BIOPHYSICS – Salette Reis THEORETICAL & COMPUTATIONAL BIOCHEMISTRY TOXICOLOGY | FUNCTIONAL MOLECULES & NANOMATERIALS BIOMODELS, BIOANALYTICS AND BIOPHYSICS

17 Drug Discovery @ UCIBIO
Working, presently, on a heavily financed drug discovery project, which focus on drugs that target diabetes and related infections

18 Drug Discovery @ UCIBIO
Thank you!


Download ppt "Drug Discovery @ UCIBIO Maria João Ramos Email: mjramos@fc.up.pt www.fc.up.pt/pessoas/mjramos/"

Similar presentations


Ads by Google